425: Strive, Semler Scientific Merger Communication

Strive, Inc. and Semler Scientific, Inc. communicate about their proposed business combination, emphasizing forward-looking statements and regulatory filings.

Summary

• The communication was reposted on X.com by Pierre Rochard, a Board Member of Strive, Inc., on October 2, 2025.
• It pertains to Strive's proposed business combination with Semler Scientific, Inc.
• The document includes a cautionary statement regarding forward-looking statements, highlighting inherent risks and uncertainties associated with the transaction.
• Strive intends to file a Registration Statement on Form S-4 with the SEC, which will include an Information Statement/Proxy Statement/Prospectus.
• Investors and stockholders of Semler Scientific are urged to read the forthcoming regulatory filings before making any voting or investment decisions.
• Strive, Semler Scientific, and certain directors/executive officers may be deemed participants in the solicitation of proxies from Semler Scientific stockholders.
• The communication explicitly states it is not an offer to sell or solicit an offer to buy any securities or a solicitation of any vote of approval.

Sentiment

Score: 5

Explanation: The filing is a procedural communication about a proposed merger, outlining potential benefits but heavily emphasizing a comprehensive list of risks and uncertainties, leading to a neutral to cautious sentiment.

Positives

• The proposed transaction is expected to yield strategic and financial benefits for the combined company.
• Anticipated cost savings and strategic gains are projected from the business combination.

Negatives

• The proposed transaction may divert management's attention from ongoing business operations and opportunities.
• Strive's issuance of additional shares of Class A common stock in connection with the transaction will cause dilution for existing shareholders.
• There is a possibility of adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships due to the announcement or completion of the transaction.
• Changes in Strive's or Semler Scientific's share price before closing are a potential negative factor.

Risks

• The merger agreement could be terminated due to various events, changes, or circumstances.
• The proposed transaction may not close as expected or at all if conditions to closing are not met or satisfied timely.
• Legal proceedings may be instituted against Strive, Semler Scientific, or the combined company, with uncertain outcomes.
• Anticipated benefits, including cost savings and strategic gains, may not be realized as expected or at all.
• Risks are associated with the implementation of Bitcoin treasury strategies and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and regulatory changes could impact the transaction.
• The integration of the two companies may be more difficult, time-consuming, or costly than anticipated.
• The proposed transaction may be more expensive or take longer to complete than expected due to unforeseen factors.
• Diversion of management's attention from ongoing business operations and opportunities is a risk.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of customers or changes to business or employee relationships resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other unknown or unpredictable factors could harm Strive, Semler Scientific, or the combined company's results.

Future Outlook

The companies anticipate strategic and financial benefits from the proposed transaction, including a positive impact on the combined company's future financial performance. They expect to successfully integrate the combined businesses, though acknowledge risks regarding the timing and realization of these benefits.

Management Comments

• Management of both Strive and Semler Scientific believes that their expectations with respect to forward-looking statements are based upon reasonable assumptions within the bounds of their existing knowledge of their business and operations.

Industry Context

The filing's mention of 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets' indicates that the proposed merger is occurring within an industry context where companies are increasingly exploring or integrating digital asset strategies, a notable trend in financial and corporate sectors.

Stakeholder Impact

• Shareholders of Strive may experience dilution due to the issuance of additional Class A common stock.
• Shareholders of Semler Scientific will need to approve the proposed transaction.
• Customers of both companies may have adverse reactions to the merger announcement or completion.
• Employee relationships at both companies could be affected by the proposed transaction.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC to register Class A common stock for the proposed transaction.
• The Registration Statement will include an Information Statement of Strive, a proxy statement of Semler Scientific, and a prospectus of Strive.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval of the proposed transaction.
• Investors and stockholders are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus, and any other relevant documents filed with the SEC, when they become available.

Key Dates

Keywords

Strive Inc, Semler Scientific Inc, Merger, Acquisition, Business Combination, SEC Filing, Form 425, Forward-Looking Statements, Bitcoin Treasury Strategy, Corporate Governance, Digital Assets